Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "financial results" return 85 results.
Ceva continues rapid growth in 2011 >
Twin pillar strategy of combining internal and external growth opportunities drives further global expansion
Second joint Human and Veterinary Cardiology Symposium >
Together for health, in the heart of Bordeaux
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio
Parasiticides >
75% of all emerging human infectious diseases are of animal origin. Thanks to its products, Ceva fight against the spread of infectious disease that can be transmitted from wild or domestic animals an...
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
USA: Ceva acquires Summit VetPharm, LLC - 26th August 2010 >
LENEXA, Kan.— Ceva, a global veterinary pharmaceutical group, is pleased to announce the company has entered into an agreement with Sumitomo Corporation of America, and Sumitomo Corporation, to acquir...
Nomination : Corporate Marketing Directors - 13th July 2010 >
Ceva reinforces the management of its marketing organisation with the recruitment of two key executives
Anti-infectives >
Antibiotic treatment is one of Ceva’s areas of expertise, with the company offering a very wide range of antibiotic molecules.
Business and scientific partnerships >
By fostering partnerships with universities, institutes, private and public research centres, Ceva is not only able to keep up with the latest advances in research, but also to expand and diversify sc...